H C Thomas|A M Lever - JoVE Visualize

Showing results (341-350 of 361) with videos related to

Pageof 37

Sort By:

Metabolic Brain Disease|March 12, 2014

Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiencyDavid A Sheridan, S H Bridge, M M E Crossey, et al.

Journal of Clinical Immunology|July 1, 1982

T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host diseaseG Janossy, L Montano, W S Selby, et al.

Journal of Viral Hepatitis|January 19, 2005

Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trialM Wright, D Forton, J Main, et al.

East African Medical Journal|November 1, 1995

Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver diseaseO S Ojo, M Thursz, H C Thomas, et al.

The Journal of Infectious Diseases|April 1, 1994

Interferon (IFN)-alpha 2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-alpha 2a therapyJ S Crowe, D R Gewert, K A Barber, et al.

Hepatology (Baltimore, Md.)|March 30, 1999

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis CS Zeuzem, U Hopf, V Carreno, et al.

Journal of Viral Hepatitis|January 14, 2012

Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammationV P B Grover, N Pavese, S-B Koh, et al.

Journal of Viral Hepatitis|December 17, 2009

Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis CA K P Lim, N Patel, R J Eckersley, et al.

Journal of Molecular and Cellular Cardiology|May 9, 1998

Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3T L Yue, C Wang, A M Romanic, et al.

Gut|December 14, 2004

Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis CA K P Lim, S D Taylor-Robinson, N Patel, et al.

Pageof 37

Showing results (341-350 of 361) with videos related to

Sort By:

Pageof 37

Metabolic Brain Disease|March 12, 2014

Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiencyDavid A Sheridan, S H Bridge, M M E Crossey, et al.

Journal of Clinical Immunology|July 1, 1982

T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host diseaseG Janossy, L Montano, W S Selby, et al.

Journal of Viral Hepatitis|January 19, 2005

Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trialM Wright, D Forton, J Main, et al.

East African Medical Journal|November 1, 1995

Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver diseaseO S Ojo, M Thursz, H C Thomas, et al.

The Journal of Infectious Diseases|April 1, 1994

Interferon (IFN)-alpha 2 genotype analysis of Chinese chronic hepatitis B patients undergoing recombinant IFN-alpha 2a therapyJ S Crowe, D R Gewert, K A Barber, et al.

Hepatology (Baltimore, Md.)|March 30, 1999

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis CS Zeuzem, U Hopf, V Carreno, et al.

Journal of Viral Hepatitis|January 14, 2012

Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammationV P B Grover, N Pavese, S-B Koh, et al.

Journal of Viral Hepatitis|December 17, 2009

Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis CA K P Lim, N Patel, R J Eckersley, et al.

Journal of Molecular and Cellular Cardiology|May 9, 1998

Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3T L Yue, C Wang, A M Romanic, et al.

Gut|December 14, 2004

Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis CA K P Lim, S D Taylor-Robinson, N Patel, et al.

Pageof 37